Showing results (31-40 of 183) with videos related to
Sort By:
Pageof 19
Carcinogenesis|May 29, 2003
p53 responsive nucleotide excision repair gene products p48 and XPC, but not p53, localize to sites of UV-irradiation-induced DNA damage, in vivoMaureen E Fitch, Irina V Cross, James M FordMutation Research|December 4, 2003
Functional characterization of global genomic DNA repair and its implications for cancerPhilip C Hanawalt, James M Ford, Daniel R LloydCancer Treatment Reviews|March 1, 2016
DNA-repair defects in pancreatic neuroendocrine tumors and potential clinical applicationsIris H Liu, James M Ford, Pamela L KunzThe Journal of Biological Chemistry|August 29, 2003
In vivo recruitment of XPC to UV-induced cyclobutane pyrimidine dimers by the DDB2 gene productMaureen E Fitch, Satoshi Nakajima, Akira Yasui, et al.Health Affairs (Project Hope)|May 8, 2018
Strategies For Clinical Implementation: Precision Oncology At Three Distinct InstitutionsLincoln D Nadauld, James M Ford, Daryl Pritchard, et al.Journal of the National Comprehensive Cancer Network : JNCCN|May 14, 2013
A young woman with bilateral breast cancer: identifying a genetic cause and implications for managementMonique A de Bruin, James M Ford, Allison W KurianCancer Genetics|March 14, 2022
Somatic tumor testing implications for Lynch syndrome germline genetic testingKathleen Barrus, Natasha Purington, Nicolette Chun, et al.JNCI Cancer Spectrum|April 8, 2020
Germline Testing for Patients With BRCA1/2 Mutations on Somatic Tumor TestingKatherine Vlessis, Natasha Purington, Nicolette Chun, et al.Journal of the American Chemical Society|July 15, 2016
A Chimeric ATP-Linked Nucleotide Enables Luminescence Signaling of Damage Surveillance by MTH1, a Cancer TargetDebin Ji, Andrew A Beharry, James M Ford, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 10, 2010
Longer relative telomere length in blood from women with sporadic and familial breast cancer compared with healthy controlsMaria M Gramatges, Melinda L Telli, Raymond Balise, et al.Pageof 19